RankingsPricing
  1. US-listed companies
  2. REGENERON PHARMACEUTICALS, INC.
  3. Financials
  4. Net income margin (%)

REGENERON PHARMACEUTICALS, INC.REGN

Market cap
$81.6B
P/E ratio
SummaryFinancials
Period EndNet income margin (%) YoY (%)
Dec 31, 202431.1+3.08%
Dec 31, 202330.1-15.43%
Dec 31, 202235.6-29.07%
Dec 31, 202150.2+21.52%
Dec 31, 202041.3+53.66%
Dec 31, 201926.9-26.13%
Dec 31, 201836.4+78.47%
Dec 31, 201720.4+10.77%
Dec 31, 201618.4+18.87%
Dec 31, 201515.5+25.55%
Dec 31, 201412.3-38.77%
Dec 31, 201320.2-62.96%
Dec 31, 201254.4-209.42%
Dec 31, 2011-49.7+118.58%
Dec 31, 2010-22.8

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)